CHSCP
Income statement / Annual
Last year (2024), CHS Inc.'s total revenue was $39.26 B,
a decrease of 13.88% from the previous year.
In 2024, CHS Inc.'s net income was $1.10 B.
See CHS Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
08/31/2024 |
08/31/2023 |
08/31/2022 |
08/31/2021 |
08/31/2020 |
08/31/2019 |
08/31/2018 |
08/31/2017 |
08/31/2016 |
08/31/2015 |
Operating Revenue |
$39.26 B
|
$45.59 B
|
$47.79 B
|
$38.45 B
|
$28.41 B
|
$31.90 B
|
$32.68 B
|
$31.93 B
|
$30.35 B
|
$34.58 B
|
Cost of Revenue |
$37.51 B |
$43.21 B |
$45.10 B |
$36.57 B |
$27.35 B |
$30.52 B |
$31.59 B |
$30.99 B |
$29.39 B |
$33.09 B |
Gross Profit |
$1.75 B |
$2.38 B |
$2.69 B |
$1.88 B |
$1.05 B |
$1.38 B |
$1.09 B |
$949.24 M |
$959.29 M |
$1.49 B |
Gross Profit Ratio |
0.04 |
0.05 |
0.06 |
0.05 |
0.04 |
0.04 |
0.03 |
0.03 |
0.03 |
0.04 |
Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$745.60 M
|
$704.54 M
|
$737.64 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$1.11 M
|
-$2.99 M
|
-$45.74 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$1.17 B
|
$1.02 B
|
$998.41 M
|
$746.71 M
|
$701.56 M
|
$691.90 M
|
$674.08 M
|
$604.36 M
|
$649.10 M
|
$775.35 M
|
Other Expenses |
$0.00 |
$0.00 |
$997.84 M |
$0.00 |
$0.00 |
$0.00 |
$78.02 M |
$95.42 M |
$0.00 |
$0.00 |
Operating Expenses |
$1.17 B |
$231.04 M |
$998.41 M |
$746.71 M |
$701.56 M |
$401.67 M |
$636.37 M |
$1.06 B |
$649.10 M |
$775.35 M |
Cost And Expenses |
$38.68 B |
$43.44 B |
$46.10 B |
$37.32 B |
$28.05 B |
$30.92 B |
$32.23 B |
$32.05 B |
$30.04 B |
$33.87 B |
Interest Income |
$0.00 |
$0.00 |
$114.16 M |
$104.57 M |
$116.98 M |
$167.07 M |
$0.00 |
$0.00 |
$38.36 M |
$10.33 M |
Interest Expense |
$104.06 M |
$151.44 M |
$120.26 M |
$112.57 M |
$126.65 M |
$167.07 M |
$149.20 M |
$171.24 M |
$113.70 M |
$70.66 M |
Depreciation &
Amortization |
$481.72 M
|
$464.62 M
|
$461.97 M
|
$461.73 M
|
$477.38 M
|
$473.21 M
|
$478.05 M
|
$480.22 M
|
$447.49 M
|
$355.42 M
|
EBITDA |
$1.68 B
|
$2.61 B
|
$2.39 B
|
$1.08 B
|
$980.00 M
|
$1.17 B
|
$1.30 B
|
$541.30 M
|
$963.32 M
|
$1.19 B
|
EBITDA Ratio |
0.04 |
0.04 |
0.05 |
0.04 |
0.03 |
0.04 |
0.04 |
0.02 |
0.03 |
0.03 |
Operating Income Ratio
|
0.01
|
0.03
|
0.04
|
0.03
|
0.01
|
0.02
|
0.01
|
-0
|
0.01
|
0.02
|
Total Other
Income/Expenses Net |
$513.43 M
|
$257.06 M
|
$115.96 M
|
-$614.41 M
|
$34.99 M
|
$156.00 M
|
$214.14 M
|
$1.63 M
|
$109.68 M
|
$52.76 M
|
Income Before Tax |
$1.10 B |
$2.01 B |
$1.81 B |
$515.32 M |
$386.88 M |
$815.60 M |
$671.23 M |
-$54.85 M |
$419.88 M |
$768.17 M |
Income Before Tax Ratio
|
0.03
|
0.04
|
0.04
|
0.01
|
0.01
|
0.03
|
0.02
|
-0
|
0.01
|
0.02
|
Income Tax Expense |
-$4.87 M |
$107.66 M |
$132.12 M |
-$38.25 M |
-$36.73 M |
$12.46 M |
-$104.08 M |
-$182.08 M |
-$4.09 M |
-$12.17 M |
Net Income |
$1.10 B |
$1.73 B |
$1.68 B |
$553.95 M |
$422.44 M |
$661.21 M |
$775.91 M |
$127.86 M |
$424.19 M |
$781.05 M |
Net Income Ratio |
0.03 |
0.04 |
0.04 |
0.01 |
0.01 |
0.02 |
0.02 |
0 |
0.01 |
0.02 |
EPS |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
EPS Diluted |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Weighted Average Shares
Out |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Weighted Average Shares
Out Diluted |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Link |
|
|
|
|
|
|
|
|
|
|